AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.91%52.950.9%$1377.29m
JNJJohnson & Johnson 1.17%179.050.7%$1368.39m
BMYBristol-Myers Squibb Co. 0.82%76.821.0%$1207.17m
MRKMerck & Co., Inc. 0.37%93.900.7%$1143.92m
ABBVAbbVie, Inc. -1.21%149.191.9%$1124.40m
LLYEli Lilly & Co. 0.83%301.331.1%$899.61m
AZNAstraZeneca Plc 0.65%66.641.0%$521.01m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.47%142.700.0%$460.66m
VERUVeru, Inc. -1.57%13.170.0%$313.66m
NVSNovartis AG 1.10%90.400.2%$253.95m
GSKGlaxoSmithKline Plc 0.60%44.790.2%$244.63m
HZNPHorizon Therapeutics Plc -2.24%88.335.4%$195.92m
NVONovo Nordisk A/S 0.08%107.840.1%$190.89m
SGENSeagen Inc. 0.10%139.785.7%$181.93m
VTRSViatris, Inc. -1.57%11.620.0%$163.59m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.